<DOC>
	<DOC>NCT00110461</DOC>
	<brief_summary>The purpose of this trial is to test the safety and efficacy of two doses of aripiprazole in child and adolescent patients with bipolar I disorder, manic or mixed episode with or without psychotic features.</brief_summary>
	<brief_title>Aripiprazole in Children and Adolescents With Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Child and adolescent patients with bipolar I disorder, manic or mixed episode with or without psychotic features Patients with certain other psychological disorders Patients with a comorbid serious, uncontrolled systemic illness Patients with significant risk of committing suicide</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Aripiprazole</keyword>
	<keyword>Bipolar I Disorder, Manic or Mixed Episode with or without Psychotic Features</keyword>
</DOC>